Format
Sort by
Items per page

Send to

Choose Destination

Best matches for irritable bowel Actinobacteria:

Effect of multispecies probiotics on irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial. Yoon JS et al. J Gastroenterol Hepatol. (2014)

Bifidobacterium bifidum MIMBb75 in irritable bowel syndrome. Quigley EM et al. Aliment Pharmacol Ther. (2011)

Effect of probiotic species on irritable bowel syndrome symptoms: A bring up to date meta-analysis. Ortiz-Lucas M et al. Rev Esp Enferm Dig. (2013)

Search results

Items: 1 to 20 of 130

1.

No Significant Association Between the Fecal Microbiome and the Presence of Irritable Bowel Syndrome-type Symptoms in Patients with Quiescent Inflammatory Bowel Disease.

Shutkever O, Gracie DJ, Young C, Wood HM, Taylor M, John Hamlin P, Ford AC, Quirke P.

Inflamm Bowel Dis. 2018 Jun 8;24(7):1597-1605. doi: 10.1093/ibd/izy052.

PMID:
29668957
2.

The Fragility of Probiotic Bifidobacterium longum NCC3001 Use for Depression in Patients With Irritable Bowel Syndrome.

Meyer C, Vassar M.

Gastroenterology. 2018 Feb;154(3):764. doi: 10.1053/j.gastro.2017.09.055. Epub 2018 Jan 17. No abstract available.

PMID:
29352957
3.

Bifidobacteria and Their Health-Promoting Effects.

Hidalgo-Cantabrana C, Delgado S, Ruiz L, Ruas-Madiedo P, Sánchez B, Margolles A.

Microbiol Spectr. 2017 Jun;5(3). doi: 10.1128/microbiolspec.BAD-0010-2016. Review.

PMID:
28643627
4.

Bifidobacterium-Rich Fecal Donor May Be a Positive Predictor for Successful Fecal Microbiota Transplantation in Patients with Irritable Bowel Syndrome.

Mizuno S, Masaoka T, Naganuma M, Kishimoto T, Kitazawa M, Kurokawa S, Nakashima M, Takeshita K, Suda W, Mimura M, Hattori M, Kanai T.

Digestion. 2017;96(1):29-38. doi: 10.1159/000471919. Epub 2017 Jun 21.

5.

A Diet Low in FODMAPs Reduces Symptoms in Patients With Irritable Bowel Syndrome and A Probiotic Restores Bifidobacterium Species: A Randomized Controlled Trial.

Staudacher HM, Lomer MCE, Farquharson FM, Louis P, Fava F, Franciosi E, Scholz M, Tuohy KM, Lindsay JO, Irving PM, Whelan K.

Gastroenterology. 2017 Oct;153(4):936-947. doi: 10.1053/j.gastro.2017.06.010. Epub 2017 Jun 15.

PMID:
28625832
6.

Beneficial effects of Rifaximin in post-infectious irritable bowel syndrome mouse model beyond gut microbiota.

Jin Y, Ren X, Li G, Li Y, Zhang L, Wang H, Qian W, Hou X.

J Gastroenterol Hepatol. 2018 Feb;33(2):443-452. doi: 10.1111/jgh.13841.

PMID:
28573746
7.

Probiotic Bifidobacterium longum NCC3001 Reduces Depression Scores and Alters Brain Activity: A Pilot Study in Patients With Irritable Bowel Syndrome.

Pinto-Sanchez MI, Hall GB, Ghajar K, Nardelli A, Bolino C, Lau JT, Martin FP, Cominetti O, Welsh C, Rieder A, Traynor J, Gregory C, De Palma G, Pigrau M, Ford AC, Macri J, Berger B, Bergonzelli G, Surette MG, Collins SM, Moayyedi P, Bercik P.

Gastroenterology. 2017 Aug;153(2):448-459.e8. doi: 10.1053/j.gastro.2017.05.003. Epub 2017 May 5.

8.

Multivariate modelling of faecal bacterial profiles of patients with IBS predicts responsiveness to a diet low in FODMAPs.

Bennet SMP, Böhn L, Störsrud S, Liljebo T, Collin L, Lindfors P, Törnblom H, Öhman L, Simrén M.

Gut. 2018 May;67(5):872-881. doi: 10.1136/gutjnl-2016-313128. Epub 2017 Apr 17.

PMID:
28416515
9.

Microbiota in Functional Gastrointestinal Disorders in Infancy: Implications for Management.

Abrahamsson TR, Wu RY, Sherman PM.

Nestle Nutr Inst Workshop Ser. 2017;88:107-115. doi: 10.1159/000455219. Epub 2017 Mar 27. Review.

PMID:
28346927
10.

Prebiotic inulin-type fructans and galacto-oligosaccharides: definition, specificity, function, and application in gastrointestinal disorders.

Wilson B, Whelan K.

J Gastroenterol Hepatol. 2017 Mar;32 Suppl 1:64-68. doi: 10.1111/jgh.13700. Review.

PMID:
28244671
11.

When the low FODMAP diet does not work.

Halmos EP.

J Gastroenterol Hepatol. 2017 Mar;32 Suppl 1:69-72. doi: 10.1111/jgh.13701. Review.

PMID:
28244666
12.

Nutritional, microbiological and psychosocial implications of the low FODMAP diet.

Staudacher HM.

J Gastroenterol Hepatol. 2017 Mar;32 Suppl 1:16-19. doi: 10.1111/jgh.13688. Review.

PMID:
28244658
13.

Efficacy of Bifidobacterium infantis 35624 in patients with irritable bowel syndrome: a meta-analysis.

Yuan F, Ni H, Asche CV, Kim M, Walayat S, Ren J.

Curr Med Res Opin. 2017 Jul;33(7):1191-1197. doi: 10.1080/03007995.2017.1292230. Epub 2017 Mar 7. Review.

PMID:
28166427
14.

A double-blind, randomized, placebo-controlled trial of Lactobacillus helveticus and Bifidobacterium longum for the symptoms of depression.

Romijn AR, Rucklidge JJ, Kuijer RG, Frampton C.

Aust N Z J Psychiatry. 2017 Aug;51(8):810-821. doi: 10.1177/0004867416686694. Epub 2017 Jan 10.

15.

A review of dose-responses of probiotics in human studies.

Ouwehand AC.

Benef Microbes. 2017 Apr 26;8(2):143-151. doi: 10.3920/BM2016.0140. Epub 2016 Dec 23. Review.

PMID:
28008787
16.
17.

Efficacy of synbiotic, probiotic, and prebiotic treatments for irritable bowel syndrome in children: A randomized controlled trial.

Baştürk A, Artan R, Yılmaz A.

Turk J Gastroenterol. 2016 Sep;27(5):439-443. doi: 10.5152/tjg.2016.16301.

18.

Effects of varying dietary content of fermentable short-chain carbohydrates on symptoms, fecal microenvironment, and cytokine profiles in patients with irritable bowel syndrome.

Hustoft TN, Hausken T, Ystad SO, Valeur J, Brokstad K, Hatlebakk JG, Lied GA.

Neurogastroenterol Motil. 2017 Apr;29(4). doi: 10.1111/nmo.12969. Epub 2016 Oct 16.

PMID:
27747984
19.

Limited prolonged effects of rifaximin treatment on irritable bowel syndrome-related differences in the fecal microbiome and metabolome.

Zeber-Lubecka N, Kulecka M, Ambrozkiewicz F, Paziewska A, Goryca K, Karczmarski J, Rubel T, Wojtowicz W, Mlynarz P, Marczak L, Tomecki R, Mikula M, Ostrowski J.

Gut Microbes. 2016 Sep 2;7(5):397-413. doi: 10.1080/19490976.2016.1215805. Epub 2016 Jul 26.

20.

Review on Bifidobacterium bifidum BGN4: Functionality and Nutraceutical Applications as a Probiotic Microorganism.

Ku S, Park MS, Ji GE, You HJ.

Int J Mol Sci. 2016 Sep 14;17(9). pii: E1544. doi: 10.3390/ijms17091544. Review.

Supplemental Content

Loading ...
Support Center